PIA
MDCO

Piedmont Investment Advisors’s Medicines Co MDCO Stock Holding History

Piedmont Investment Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,562
Closed -$463K – 1364
2019
Q1 		$463K Buy
16,562
+864
+6% +$20.4K 0.02% 568
2018
Q4 		$300K Buy
15,698
+517
+3% +$12K 0.01% 725
2018
Q3 		$454K Buy
15,181
+16
+0.1% +$603 0.02% 574
2018
Q2 		$557K Sell
15,165
-30,067
-66% -$977K 0.03% 410
2018
Q1 		$1.49M Buy
45,232
+598
+1% +$18.7K 0.04% 280
2017
Q4 		$1.22M Buy
44,634
+30,711
+221% +$946K 0.02% 302
2017
Q3 		$516K Sell
13,923
-1,681
-11% -$62K 0.01% 414
2017
Q2 		$593K Buy
15,604
+11,335
+266% +$505K 0.01% 375
2017
Q1 		$209K Buy
+4,269
New +$195K ﹤0.01% 393

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Piedmont Investment Advisors's MDCO Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Medicines Co (MDCO) in Q2 2019, closing a stake of 16,562 shares — an estimated $463K sold.

Piedmont Investment Advisors first reported a position in MDCO in Q1 2017 and held it in 9 quarters. The position peaked at $1.49M in Q1 2018. 228 funds tracked by Wall St. Rank hold MDCO as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Medicines Co position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 16,562 Medicines Co shares in Q2 2019, an estimated $463K.
  • Piedmont Investment Advisors first reported a position in Medicines Co in Q1 2017 and held it in 9 quarters.
  • Piedmont Investment Advisors's Medicines Co position peaked at $1.49M in Q1 2018.
  • 228 funds tracked by Wall St. Rank held Medicines Co as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.